43 related articles for article (PubMed ID: 38745333)
1. Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma.
Roohani S; Wiltink LM; Kaul D; Spałek MJ; Haas RL
Curr Treat Options Oncol; 2024 Apr; 25(4):543-555. PubMed ID: 38478330
[TBL] [Abstract][Full Text] [Related]
2. Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.
Murakami M; Ishikawa H; Sekino Y; Nishiyama H; Suzuki H; Sugahara S; Iizumi T; Mizumoto M; Okumura T; Keino N; Iizumi Y; Hashimoto K; Gosho M; Sakurai H
J Radiat Res; 2024 May; 65(3):402-407. PubMed ID: 38739903
[TBL] [Abstract][Full Text] [Related]
3. The IMRiS Trial: A Phase II Study of Intensity-Modulated Radiotherapy in Extremity Soft Tissue Sarcoma.
Seddon B; Grange FL; Simões R; Stacey C; Shelly S; Forsyth S; White L; Candish C; Dickinson P; Miah A; Moinuddin SA; Wylie J; Lopes A
Int J Radiat Oncol Biol Phys; 2024 Jun; ():. PubMed ID: 38866214
[TBL] [Abstract][Full Text] [Related]
4. Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue Sarcomas.
Bryant JM; Mills MN; Yang GQ; Liveringhouse C; Palm R; Johnstone PA; Miller JT; Latifi K; Feygelman V; Naghavi AO
Adv Radiat Oncol; 2024 Apr; 9(4):101447. PubMed ID: 38778821
[TBL] [Abstract][Full Text] [Related]
5. CORR Insights®: Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Healey JH
Clin Orthop Relat Res; 2018 Mar; 476(3):645-647. PubMed ID: 29443851
[No Abstract] [Full Text] [Related]
6. Clinical Trials Radiographers identifying priority challenges associated with implementing a national programme of clinical trials in the United Kingdom's first proton beam therapy centre.
Davies LSC; McHugh L; Falk S; Bridge J; Amaro PF; Whiteside L; Bailey R; Webb J; Eccles CL
BJR Open; 2024 Jan; 6(1):tzae012. PubMed ID: 38873402
[TBL] [Abstract][Full Text] [Related]
7. Superoxide Dismutase Mimetic Avasopasem Manganese Enhances Radiation Therapy Effectiveness in Soft Tissue Sarcomas and Accelerates Wound Healing.
Zaher A; Mapuskar KA; Petronek MS; Tanas MR; Isaacson AL; Dodd RD; Milhem M; Furqan M; Spitz DR; Miller BJ; Beardsley RA; Allen BG
Antioxidants (Basel); 2024 May; 13(5):. PubMed ID: 38790692
[TBL] [Abstract][Full Text] [Related]
8. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract][Full Text] [Related]
9. Comparing Ultra-hypofractionated Proton versus Photon Therapy in Extremity Soft Tissue Sarcoma.
Thomas R; Chen H; Gogineni E; Halthore A; Floreza B; Esho-Voltaire T; Weaver A; Alcorn S; Ladra M; Li H; Deville C
Int J Part Ther; 2023; 9(3):30-39. PubMed ID: 36721484
[TBL] [Abstract][Full Text] [Related]
10. Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma.
Bedi M; Singh R; Charlson JA; Kelly T; Johnstone C; Wooldridge A; Hackbarth DA; Moore N; Neilson JC; King DM
Adv Radiat Oncol; 2022; 7(3):100850. PubMed ID: 35647402
[TBL] [Abstract][Full Text] [Related]
11. Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline.
Salerno KE; Alektiar KM; Baldini EH; Bedi M; Bishop AJ; Bradfield L; Chung P; DeLaney TF; Folpe A; Kane JM; Li XA; Petersen I; Powell J; Stolten M; Thorpe S; Trent JC; Voermans M; Guadagnolo BA
Pract Radiat Oncol; 2021; 11(5):339-351. PubMed ID: 34326023
[TBL] [Abstract][Full Text] [Related]
12. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial.
Gobo Silva ML; Lopes de Mello CA; Aguiar Junior S; D'Almeida Costa F; Stevanato Filho PR; Santoro Bezerra T; Nakagawa SA; Nascimento AG; Werneck da Cunha I; Spencer Sobreira Batista RM; Nicolau Daher UR; Da Cruz Formiga MN; Germano JN; Catin Kupper BE; De Assis Pellizzon AC; Lopes A
Radiother Oncol; 2021 Jun; 159():161-167. PubMed ID: 33798613
[TBL] [Abstract][Full Text] [Related]
14. Early Outcomes of Preoperative 5-Fraction Radiation Therapy for Soft Tissue Sarcoma Followed by Immediate Surgical Resection.
Parsai S; Lawrenz J; Kilpatrick S; Rubin B; Hymes C; Gray M; Mesko N; Shah C; Nystrom L; Scott JG
Adv Radiat Oncol; 2020; 5(6):1274-1279. PubMed ID: 33305088
[TBL] [Abstract][Full Text] [Related]
15. Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial.
Lansu J; Bovée JVMG; Braam P; van Boven H; Flucke U; Bonenkamp JJ; Miah AB; Zaidi SH; Thway K; Bruland ØS; Baldini EH; Jebsen NL; Scholten AN; van den Ende PLA; Krol ADG; Ubbels JF; van der Hage JA; van Werkhoven E; Klomp HM; van der Graaf WTA; van Coevorden F; Schrage Y; van Houdt WJ; Haas RL
JAMA Oncol; 2021 Jan; 7(1):e205865. PubMed ID: 33180100
[TBL] [Abstract][Full Text] [Related]
16. A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.
Kalbasi A; Kamrava M; Chu FI; Telesca D; Van Dams R; Yang Y; Ruan D; Nelson SD; Dry SM; Hernandez J; Chmielowski B; Singh AS; Bukata SV; Bernthal NM; Steinberg ML; Weidhaas JB; Eilber FC
Clin Cancer Res; 2020 Apr; 26(8):1829-1836. PubMed ID: 32054730
[TBL] [Abstract][Full Text] [Related]
17. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.
Pennington JD; Eilber FC; Eilber FR; Singh AS; Reed JP; Chmielowski B; Eckardt JJ; Bukata SV; Bernthal NM; Federman N; Nelson SD; Dry SM; Wang PC; Luu M; Selch MT; Steinberg ML; Kalbasi A; Kamrava M
Am J Clin Oncol; 2018 Dec; 41(12):1154-1161. PubMed ID: 29664796
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
